Lishomwa C. Ndhlovu is supported and reports grants from the NIH under award R01MH130197 and has received consulting fees from work as a scientific advisor for AbbVie, ViiV Healthcare, and Cytodyn and also serves on the Board of Directors of CytoDyn and has financial interests in Ledidi AS all for work outside of the submitted work.
https://link.springer.com/article/10.1007/s13365-024-01223-w
___
Was he Cytodyn's past primary person of science contact, to guide any past cross-linking studies